Skip to main content
. 2015 May 15;6:104. doi: 10.3389/fneur.2015.00104

Table 2.

Phenotypic variability in patients with the p.Arg1617Gln mutation in SCN8A.

Patient Age of onset Seizure type Developmental progression EEG Drug response Reference
1 3 months Febrile seizures, tonic–clonic Sat, crawled 24 months Normal at 3 months CBZ temp. effective (23)
2 5.5 months Generalized tonic–clonic, tonic, clonic, myoclonic, atypical absence Hypotonia, wheelchair-bound, no speech, SUDEP at 3 years Bilateral delta slowing and left temporal spikes and/or slow waves Refractory (25)
3 6 months Generalized tonic Head control 7 months., sat 12 months Normal at 11 months, spike and spike–wave complexes in left rolandic at 3 years OXC effective (53)
4 7 months Generalized tonic–clonic Spasticity, sat 8 months, walked 17 months, speech 24 months Not described No details (16)
5 12 months Generalized tonic–clonic Not described Suggested anterior midline-frontal onset Refractory (21)